Status:
COMPLETED
Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection
Lead Sponsor:
Statens Serum Institut
Collaborating Sponsors:
Hvidovre University Hospital
Rigshospitalet, Denmark
Conditions:
HIV Infections
Eligibility:
MALE
18-50 years
Phase:
PHASE1
Brief Summary
Phase I test of concept study: In an attempt to induce new immunity to HIV-1 during untreated HIV-1 infection the investigators have identified relatively immune silent immune subdominant HLA-A2-restr...
Eligibility Criteria
Inclusion
- HIV positive male
- Viral load \>1000/ml
- CD4 count \>300
- HLA-A2 tissue type
- 18-50 years of age
- Able to follow the instructions
- Informed consent
Exclusion
- Treated with other experimental vaccines or immune modulatig medicine
- Other chronic infectious diseases
- Allergy or autoimmune disease
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00856154
Start Date
January 1 2007
End Date
October 1 2008
Last Update
April 8 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, DK-2100